Compared to these methods, our method combined FOBT with three methylation markers (BMP3, NDRG4, and SDC2) and showed a higher sensitivity and diagnostic performance for CRC (sensitivity: 85.42%, AUC: 0.91). This evidence concerns the gene SDC2 and colorectal carcinoma.